Adtralza Euroopa Liit - eesti - EMA (European Medicines Agency)

adtralza

leo pharma a/s - tralokinumab - dermatiit, atoopiline - muud dermatoloogilised preparaadid - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.

Mavrik® Eesti - eesti - Adama

mavrik®

adama - õlivesiemulsioon - tau–fluvalinaat - insektitsiidid

Truvelog Mix 30 Euroopa Liit - eesti - EMA (European Medicines Agency)

truvelog mix 30

sanofi winthrop industrie - aspartinsuliin - diabeet mellitus - diabeetis kasutatavad ravimid - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.

Kimmtrak Euroopa Liit - eesti - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastilised ained - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.